Skip to main content
TipRanks
Go Ultimate75% OFF

Bio-Techne (TECH) Adjusted Operating Income by Segment

536 Followers

Adjusted Operating Income by Segment

Bio-Techne reported adjusted operating income by segment of $5.90M in Q1 FY2027, down 41.4% from Q4 FY2026 and down 33.6% year over year. The highest value was $19.41M in Q3 FY2022.

Presents segment profits after removing one-time charges and accounting adjustments to reveal underlying operating performance. Helps you judge the durability of margins and whether reported improvements reflect real efficiency gains or temporary items.

$0.00$5.00M$10.00M$15.00M$20.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Diagnostics & Spatial Biology has been highly lumpy—periodic large swings and a pronounced mid‑2023 trough point to one‑off timing, product mix, or acquisition-related effects rather than steady organic growth. The past several quarters show a clearer, sustained upswing, suggesting operational normalization and reduced downside risk versus the 2023 disruption. Still, the historical volatility implies earnings remain sensitive to project timing and mix; treat short‑term quarters as noisy until management demonstrates durable margin improvements or steadier revenue drivers.

TECH Adjusted Operating Income by Segment

PeriodDiagnostics and Spatial Biology
Q1 FY2027Sep 30, 2026$5.90M
Q4 FY2026Jun 30, 2026$10.07M
Q3 FY2026Mar 31, 2026$10.32M
Q2 FY2026Dec 31, 2025$8.43M
Q1 FY2026Sep 30, 2025$8.88M
Q4 FY2025Jun 30, 2025$5.38M
Q3 FY2025Mar 31, 2025$8.42M
Q2 FY2025Dec 31, 2024$3.24M
Q1 FY2025Sep 30, 2024$4.28M
Q4 FY2024Jun 30, 2024$11.36M
Q3 FY2024Mar 31, 2024$8.10M
Q2 FY2024Dec 31, 2023$4.56M
Q1 FY2024Sep 30, 2023$527.00K
Q4 FY2023Jun 30, 2023$14.64M
Q3 FY2023Mar 31, 2023$11.46M
Q2 FY2023Dec 31, 2022$8.30M
Q1 FY2023Sep 30, 2022$8.64M
Q4 FY2022Jun 30, 2022$11.23M
Q3 FY2022Mar 31, 2022$19.41M
Q2 FY2022Dec 31, 2021$10.88M
Q1 FY2022Sep 30, 2021$7.46M
Q4 FY2021Jun 30, 2021$11.23M
Q3 FY2021Mar 31, 2021$10.42M
Q2 FY2021Dec 31, 2020$8.11M
Q1 FY2021Sep 30, 2020$8.67M

Related KPIs